Drug Profile
TPW 146
Alternative Names: TPW-146Latest Information Update: 07 Mar 2016
Price :
$50
*
At a glance
- Originator Teikoku Pharma USA
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chemotherapy-induced nausea and vomiting
Most Recent Events
- 07 Mar 2016 Discontinued - Preclinical for Chemotherapy induced nausea and vomiting in USA (Transdermal)
- 18 Dec 2014 Preclinical trials in Chemotherapy induced nausea and vomiting in USA (Transdermal)